| Paralogue | Variant | Associated Disease | Mapping Quality | Consensus | Pubmed |
|---|---|---|---|---|---|
| SCN1A | N762D | Dravet syndrome C ? | Medium | 9 | 21248271 |
To assess whether the paralogue annotation here confidently predicts that variation at this residue is pathogenic, it is important to check the reports in the Pubmed links above to ascertain that the mutations in these paralogues have been proved likely to be disease-causing. It is also important to check that the direction of effect of the variant in the paralogue is compatible with your observed phenotype in CACNA1C.
| CACNA1C | -----AHR-ISKSKFSRYWRRWNRFCRRKC>R<AAVKSNVFYWLVIFLVFLNTLTIASEHYNQ | 548 |
| CACNA1A | -----SIK-SAKLENSTFFHKKERRMRFYI>R<RMVKTQAFYWTVLSLVALNTLCVAIVHYNQ | 511 |
| CACNA1B | -----SLK-SGKTESSSYFRRKEKMFRFFI>R<RMVKAQSFYWVVLCVVALNTLCVAMVHYNQ | 507 |
| CACNA1D | -----GQA-ISKSKLSRRWRRWNRFNRRRC>R<AAVKSVTFYWLVIVLVFLNTLTISSEHYNQ | 567 |
| CACNA1E | -----SIK-SAKVDGVSYFRHKERLLRISI>R<HMVKSQVFYWIVLSLVALNTACVAIVHHNQ | 500 |
| CACNA1F | -----LNK-IMKTRVCRRLRRANRVLRARC>R<RAVKSNACYWAVLLLVFLNTLTIASEHHGQ | 553 |
| CACNA1G | --------SLGPDAEPSSVLAFWRLICDTF>R<KIVDSKYFGRGIMIAILVNTLSMGIEYHEQ | 767 |
| CACNA1H | SPQRRAQQRAAPGE-PGWMGRLWVTFSGKL>R<RIVDSKYFSRGIMMAILVNTLSMGVEYHEQ | 817 |
| CACNA1I | -KEEEEEE-QADGA-VWLCGDVWRETRAKL>R<GIVDSKYFNRGIMMAILVNTVSMGIEHHEQ | 664 |
| CACNA1S | -----LNK-I--IQFIRHWRQWNRIFRWKC>H<DIVKSKVFYWLVILIVALNTLSIASEHHNQ | 456 |
| SCN10A | -----LTS-LSQKYLIWDCCPMWVKLKTIL>F<GLVTDPFAELTITLCIVVNTIFMAMEHHGM | 689 |
| SCN11A | -----GEN-LASKYLVWNCCPQWLCVKKVL>R<TVMTDPFTELAITICIIINTVFLAMEHHKM | 601 |
| SCN1A | -----WYK-FSNIFLIWDCSPYWLKVKHVV>N<LVVMDPFVDLAITICIVLNTLFMAMEHYPM | 792 |
| SCN2A | -----WYK-FANMCLIWDCCKPWLKVKHLV>N<LVVMDPFVDLAITICIVLNTLFMAMEHYPM | 783 |
| SCN3A | -----WYR-FANVFLIWDCCDAWLKVKHLV>N<LIVMDPFVDLAITICIVLNTLFMAMEHYPM | 784 |
| SCN4A | -----WYK-CAHKVLIWNCCAPWLKFKNII>H<LIVMDPFVDLGITICIVLNTLFMAMEHYPM | 602 |
| SCN5A | -----WNR-LAQRYLIWECCPLWMSIKQGV>K<LVVMDPFTDLTITMCIVLNTLFMALEHYNM | 741 |
| SCN7A | -----WYK-FAKTFLIWNCSPCWLKLKEFV>H<RIIMAPFTDLFLIICIILNVCFLTLEHYPM | 529 |
| SCN8A | -----WYK-FANTFLIWECHPYWIKLKEIV>N<LIVMDPFVDLAITICIVLNTLFMAMEHHPM | 777 |
| SCN9A | -----WYR-FAHKFLIWNCSPYWIKFKKCI>Y<FIVMDPFVDLAITICIVLNTLFMAMEHHPM | 757 |
| cons | > < |
| Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
|---|---|---|---|---|---|
| p.R518C | c.1552C>T | Inherited Arrhythmia | LQTS | SIFT: Polyphen: | |
| Reports | Inherited Arrhythmia | LQTS | Identification and Functional Characterization of a Novel CACNA1C-Mediated Cardiac Disorder Characterized by Prolonged QT Intervals with Hypertrophic Cardiomyopathy, Congenital Heart Defects, and Sudden Cardiac Death. Circ Arrhythm Electrophysiol. 2015 26253506 | ||
| p.R518H | c.1553G>A | Inherited Arrhythmia | LQTS | SIFT: Polyphen: | |
| Reports | Inherited Arrhythmia | LQTS | Identification and Functional Characterization of a Novel CACNA1C-Mediated Cardiac Disorder Characterized by Prolonged QT Intervals with Hypertrophic Cardiomyopathy, Congenital Heart Defects, and Sudden Cardiac Death. Circ Arrhythm Electrophysiol. 2015 26253506 | ||